RxDoctor Payments Data

Sharla Cantrell

Adult Health · Dayton, OHNPI 1164918322

Payments from drug & device makers

$728in general payments, 2019–2025

Across 32 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$147
  • Urovant Sciences Inc$86
  • AstraZeneca$85
  • Idorsia Pharmaceuticals US Inc$77
  • Boehringer Ingelheim$62
  • Sunovion Pharmaceuticals Inc.$62
  • plus $210 from 11 others

What the payments were for

  • Food & beverage$728100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$728 in reported general payments places this provider in the 65th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$102,890
Medicare patients
220
Services billed
1,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron53$13,772
OzempicSemaglutide13$13,424
ErtapenemErtapenem Sodium16$10,568
EliquisApixaban32$10,010
VascepaIcosapent Ethyl26$4,644
LokelmaSodium Zirconium Cyclosilicate20$3,825
Humalog Kwikpen U-100Insulin Lispro18$2,946
Midodrine Hcl13$1,441
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,408
Memantine Hcl46$1,263
Oxycodone Hcl67$1,075
Atorvastatin Calcium67$1,075
Gabapentin52$1,063
Levothyroxine Sodium59$805
Metformin Hcl61$791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$15$13,77253 claims
Novo NordiskOzempic$13$13,42413 claims
AstraZenecaLokelma$85$3,82520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,184 adult health providers in Ohio.

Other adult health in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →